Kagawa, Japan

Taiichiro Iwakura

This inventor holds 1 USPTO granted patent. Top assignees: Kaken Pharmaceutical Company, Ltd., Nippon Kayaku Kabushiki Kaisha, Teikoku Seiyaku Kabushiki Kaisha. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Taiichiro Iwakura: Innovator in Sheet-like Preparations

Introduction

Taiichiro Iwakura is a notable inventor based in Kagawa, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly with his innovative sheet-like preparation that is designed for oral cavity administration. His work exemplifies the intersection of science and practical application in medicine.

Latest Patents

Iwakura holds a patent for a sheet-like preparation that comprises a composition of essential constituents including a drug, gelatin or agar, gluten, a carboxyvinyl polymer, a polyhydric alcohol, a gum, and wax, along with water in a specified range. This preparation is particularly useful for oral cavity administration, showcasing his commitment to enhancing drug delivery methods.

Career Highlights

Throughout his career, Taiichiro Iwakura has worked with prominent companies in the pharmaceutical industry, including Kaken Pharmaceutical Company, Ltd. and Nippon Kayaku Kabushiki Kaisha. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical technology.

Collaborations

Iwakura has collaborated with notable colleagues such as Yukio Aouda and Tadafumi Mizobuchi. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment that encourages innovation.

Conclusion

Taiichiro Iwakura's contributions to the field of pharmaceutical preparations highlight his role as an innovator. His patent for a sheet-like preparation demonstrates his dedication to improving drug delivery systems. His work continues to influence the pharmaceutical industry and enhance patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…